Many Americans think they pay too much for their prescription drugs, especially those who need life-saving medications for cancer and hepatitis C. Why are drug costs so high in the United States? How can reporters better explain the cost squeeze to their audiences?
These were among the questions that Sarah Emond, M.P.P., executive vice president at the Institute for Clinical and Economic Review (ICER) in Boston and Peter Bach, M.D., director of the Memorial Sloan Kettering’s Center for Health Policy and Outcomes in New York City addressed at the Feb. 15 meeting of AHCJ’s New York chapter. Dan Goldberg of Politico moderated the session. Continue reading
Diabetes incidence among older adults is skyrocketing and it’s only going to get worse, according to the American Diabetes Association. Nearly 12 million adults over age 65 in the U.S. — about one-quarter of the population — now live with diagnosed or undiagnosed diabetes.
Untreated or poorly managed diabetes can lead to many other major health problems, such as heart disease, amputations, kidney failure and vision impairment. The condition also increases the risk for emergency department visits and hospitalizations, along with a greater risk of death. Continue reading
Wellness apps. Wearables. Middleware. Big data.
These buzzwords circulating around the health tech world are out, so declared a panel of health investors last week.
Products that reduce costs and/or improve efficiencies are in, they said.
The shift was striking after years of direct-to-consumer and wellness applications taking center stage at tech confabs and in the media.
Health reporters get pitches on digital health products all the time. Keeping up with what investors are looking for in new products and technologies can help us gauge the value of the pitch. Continue reading
The average price of brand-name prescription drugs rose almost 130 times faster than inflation in 2015 — 15.5 percent compared with 0.1 percent. New data points to increasing medication affordability problems for older adults, putting many of them at risk, according to a new report.
Researchers from the AARP Public Policy Institute studied trends in the retail prices of 268 brand name drugs widely used by older Americans between 2006 and 2015. Continue reading
We may need a new hashtag to supplement #surprisemedbills. Perhaps #shockingmedbills would fit because some bills are just that.
Recent coverage about a new mom in Utah who was charged $39.35 just to hold her newborn is a good example. Continue reading